InvestSMART

THC Global Group Limited (ASX: THC) - Announcements

Current share price for THC : $0.230 0.005 (2.13%)+

ASX company news and announcements for THC Global Group Limited (THC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All THC Global Group Limited (THC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than THC Global Group Limited (THC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for THC Global Group Limited (THC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$44 Proposed issue of Securities - THC 22 May 2020 6:38PM $0.375 $0.230 fallen by 38.67%
$44 THC Global cannabis product available via prescription 21 May 2020 9:23AM $0.330 $0.230 fallen by 30.30%
$44 THC Global appoints joint company secretaries 12 May 2020 5:33PM $0.330 $0.230 fallen by 30.30%
$44 THC Global acquires leading clinic network Tetra Health 12 May 2020 10:12AM $0.300 $0.230 fallen by 23.33%
$44 Trading Halt 8 May 2020 9:57AM $0.300 $0.230 fallen by 23.33%
$44 Cleansing Statement 4 May 2020 8:36AM $0.310 $0.230 fallen by 25.81%
$44 Proposed issue of Securities - THC 4 May 2020 8:16AM $0.310 $0.230 fallen by 25.81%
$44 THC Global Quarterly Update & Appendix 4C 30 Apr 2020 1:23PM $0.325 $0.230 fallen by 29.23%
$44 THC Global Secures $4m Debt Facility 30 Apr 2020 12:27PM $0.320 $0.230 fallen by 28.13%
$44 Medicinal Cannabis Australian Release and Export Update 22 Apr 2020 9:20AM $0.310 $0.230 fallen by 25.81%
$44 Appendix 4G and Corporate Governance Statement 31 Mar 2020 8:27PM $0.215 $0.230 risen by 6.98%
$44 Annual Report 31 Mar 2020 8:25PM $0.215 $0.230 risen by 6.98%
$44 Appendix 3C 24 Mar 2020 3:38PM $0.205 $0.230 risen by 12.20%
$44 Performance Shares Buyback and Cancellation 24 Mar 2020 3:35PM $0.205 $0.230 risen by 12.20%
$44 Production commenced to support 6000 Australian Patients 3 Mar 2020 8:56AM $0.310 $0.230 fallen by 25.81%
$44 Preliminary Final Report 2 Mar 2020 8:48AM $0.310 $0.230 fallen by 25.81%
$44 Trading Halt 28 Feb 2020 2:28PM $0.310 $0.230 fallen by 25.81%
$44 Pause in Trading 28 Feb 2020 2:12PM $0.310 $0.230 fallen by 25.81%
$44 Launch of Australian and International Medicines Supply 10 Feb 2020 9:52AM $0.370 $0.230 fallen by 37.84%
$44 Response to ASX Appendix 4C Query 7 Feb 2020 3:25PM $0.370 $0.230 fallen by 37.84%
$44 THC Global Quarterly Update & Appendix 4C 31 Jan 2020 10:15AM $0.375 $0.230 fallen by 38.67%
$44 TGA GMP Manufacturing Licence Granted for Southport Facility 21 Jan 2020 9:17AM $0.390 $0.230 fallen by 41.03%
$44 Trading Halt 20 Jan 2020 9:52AM $0.390 $0.230 fallen by 41.03%
$44 Product Supply Agreement Signed with MGC Pharma 20 Jan 2020 9:36AM $0.390 $0.230 fallen by 41.03%
$44 MXC: Supply Agreement with THC Global for Canndeo Products 20 Jan 2020 9:27AM $0.390 $0.230 fallen by 41.03%

51 - 75 of 307 results

Page 3 of 13

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.